by Christos Evangelou, MSc, PhD – Medical Writer and Editor In a new study, researchers found that contrast-enhanced ultrasound (CEUS) may help solve a longstanding challenge faced by clinicians — the characterization of indeterminate liver lesions in patients at risk for hepatocellular carcinoma (HCC). The international, multicenter trial CEUS LI-RADS demonstrated that, when […]
Source